ISIN | LU1048648056 |
---|---|
Valor Number | 25008423 |
Bloomberg Global ID | |
Fund Name | Swiss Rock Aktien Europa B |
Fund Provider |
Swiss Rock Asset Management AG
Zürich, Switzerland Phone: +41 44 360 57 00 E-Mail: info@swiss-rock.ch Web: www.swiss-rock.ch |
Fund Provider | Swiss Rock Asset Management AG |
Representative in Switzerland |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
Distributor(s) |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
Investment Strategy *** | Top tier performance in european equity with a rock solid investment approach, rotating investment styles. |
Peculiarities |
Current Price * | 21.89 EUR | 18.07.2025 |
---|---|---|
Previous Price * | 21.94 EUR | 17.07.2025 |
52 Week High * | 22.21 EUR | 06.06.2025 |
52 Week Low * | 18.53 EUR | 09.04.2025 |
NAV * | 21.89 EUR | 18.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 47,518,888 | |
Unit/Share Assets *** | 21,842,659 | |
Trading Information SIX |
YTD Performance | +11.12% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
---|---|---|
YTD Performance (in CHF) | +10.33% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
1 month | +1.16% |
18.06.2025 - 18.07.2025
18.06.2025 18.07.2025 |
3 months | +9.12% |
22.04.2025 - 18.07.2025
22.04.2025 18.07.2025 |
6 months | +7.67% |
20.01.2025 - 18.07.2025
20.01.2025 18.07.2025 |
1 year | +10.33% |
18.07.2024 - 18.07.2025
18.07.2024 18.07.2025 |
2 years | +30.84% |
18.07.2023 - 18.07.2025
18.07.2023 18.07.2025 |
3 years | +47.51% |
18.07.2022 - 18.07.2025
18.07.2022 18.07.2025 |
5 years | +71.15% |
20.07.2020 - 18.07.2025
20.07.2020 18.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 3.05% | |
---|---|---|
Novartis AG Registered Shares | 2.65% | |
ASML Holding NV | 2.44% | |
Novo Nordisk AS Class B | 2.17% | |
HSBC Holdings PLC | 2.05% | |
Siemens AG | 1.96% | |
AstraZeneca PLC | 1.79% | |
Allianz SE | 1.60% | |
Unilever PLC | 1.59% | |
Roche Holding AG | 1.53% | |
Last data update | 31.03.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.55% |
Ongoing Charges *** | 0.87% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |